| |
| |
|
| Insider
Information: |
Ignelzi Troy A. |
| Relationship: |
|
| City: |
Plymouth |
| State: |
MI |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
30,487 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
30,487 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Scpharmaceuticals Inc. |
SCPH |
|
|
0 |
|
0 |
Premium* |
|
|
Karuna Therapeutics, Inc. |
KRTX |
|
2023-08-22 |
30,487 |
2020-03-02 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
65 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| KRTX |
Karuna Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2023-02-09 |
4 |
A |
$0.00 |
$0 |
D/D |
8,650 |
30,487 |
0 |
- |
|
| KRTX |
Karuna Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2020-03-02 |
4 |
AS |
$86.50 |
$648,750 |
D/D |
(7,500) |
0 |
0 |
- |
|
| KRTX |
Karuna Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2020-05-08 |
4 |
AS |
$83.38 |
$625,350 |
D/D |
(7,500) |
0 |
0 |
- |
|
| KRTX |
Karuna Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2020-06-15 |
4 |
AS |
$89.62 |
$538,480 |
D/D |
(6,000) |
0 |
0 |
- |
|
| KRTX |
Karuna Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2020-06-16 |
4 |
AS |
$100.00 |
$200,000 |
D/D |
(2,000) |
0 |
0 |
- |
|
| KRTX |
Karuna Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2020-07-08 |
4 |
AS |
$98.32 |
$789,920 |
D/D |
(8,000) |
0 |
0 |
- |
|
| KRTX |
Karuna Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2020-09-08 |
4 |
AS |
$73.30 |
$146,600 |
D/D |
(2,000) |
5,000 |
0 |
- |
|
| KRTX |
Karuna Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2020-11-06 |
4 |
AS |
$108.15 |
$60,997 |
D/D |
(564) |
5,000 |
0 |
- |
|
| KRTX |
Karuna Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2020-11-09 |
4 |
AS |
$105.02 |
$982,847 |
D/D |
(9,318) |
5,000 |
0 |
- |
|
| KRTX |
Karuna Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2020-11-10 |
4 |
AS |
$103.48 |
$12,211 |
D/D |
(118) |
5,000 |
0 |
- |
|
| KRTX |
Karuna Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2021-01-08 |
4 |
AS |
$104.49 |
$835,920 |
D/D |
(8,000) |
13,000 |
0 |
- |
|
| KRTX |
Karuna Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2021-02-16 |
4 |
AS |
$119.57 |
$1,195,700 |
D/D |
(10,000) |
13,000 |
0 |
- |
|
| KRTX |
Karuna Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2021-05-10 |
4 |
AS |
$110.07 |
$770,490 |
D/D |
(7,000) |
13,000 |
0 |
- |
|
| KRTX |
Karuna Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2021-05-12 |
4 |
AS |
$120.00 |
$24,000 |
D/D |
(200) |
13,000 |
0 |
- |
|
| KRTX |
Karuna Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2021-09-08 |
4 |
AS |
$116.16 |
$885,726 |
D/D |
(7,600) |
18,000 |
0 |
- |
|
| KRTX |
Karuna Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2021-09-09 |
4 |
AS |
$120.05 |
$60,025 |
D/D |
(500) |
18,000 |
0 |
- |
|
| KRTX |
Karuna Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2021-09-10 |
4 |
AS |
$120.05 |
$228,095 |
D/D |
(1,900) |
18,000 |
0 |
- |
|
| KRTX |
Karuna Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2021-11-08 |
4 |
AS |
$152.32 |
$2,056,320 |
D/D |
(13,500) |
18,000 |
0 |
- |
|
| KRTX |
Karuna Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2022-02-15 |
4 |
AS |
$111.14 |
$166,710 |
D/D |
(1,500) |
24,970 |
0 |
- |
|
| KRTX |
Karuna Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2022-04-19 |
4 |
AS |
$130.81 |
$457,835 |
D/D |
(3,500) |
24,970 |
0 |
- |
|
| KRTX |
Karuna Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2022-04-20 |
4 |
AS |
$133.20 |
$93,773 |
D/D |
(704) |
24,970 |
0 |
- |
|
| KRTX |
Karuna Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2022-04-21 |
4 |
AS |
$134.46 |
$5,378 |
D/D |
(40) |
24,970 |
0 |
- |
|
| KRTX |
Karuna Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2022-08-09 |
4 |
AS |
$227.83 |
$3,759,195 |
D/D |
(16,500) |
24,970 |
0 |
- |
|
| KRTX |
Karuna Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2022-11-15 |
4 |
AS |
$225.85 |
$3,726,525 |
D/D |
(16,500) |
9,970 |
0 |
- |
|
| KRTX |
Karuna Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2023-01-17 |
4 |
AS |
$201.41 |
$164,552 |
D/D |
(817) |
21,837 |
0 |
- |
|
65 Records found
|
|
Page 1 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
